The Australian Medicinal Cannabis Landscape

Australia's cannabis industry stands at a pivotal moment in its evolution, transitioning from an emerging therapeutic sector into a sophisticated, regulated medicinal cannabis market valued at over AUD$700 million at the patient level. Since the federal legalization of medicinal cannabis in 2016, Australia has witnessed remarkable growth, with over 200,000 prescription approvals expected by the end of 2025—a 27% increase from the previous year. This expansion reflects not only growing patient demand but also increasing physician acceptance and evolving regulatory frameworks that continue to improve access.

Unlike many international markets, Australia's cannabis sector focuses primarily on medicinal applications, with recreational use remaining federally illegal (though the Australian Capital Territory has decriminalized personal possession). This medical-first approach has fostered a rigorous, pharmaceutical-grade industry overseen by the Therapeutic Goods Administration (TGA) and the Office of Drug Control (ODC), ensuring product safety, quality, and controlled distribution that aligns with international best practices.

The Australian cannabis event calendar, while more compact than its North American counterparts, offers strategic opportunities for healthcare professionals, researchers, cultivators, manufacturers, investors, and policy advocates to connect, learn, and advance the industry. From academic symposiums examining clinical applications to industry conferences showcasing cultivation innovations and business opportunities, Australia's cannabis gatherings serve as essential platforms for knowledge exchange and professional development.

For businesses operating in Australia's cannabis sector, strategic brand presence at these critical events is essential for building relationships and establishing credibility. Companies like MunchMakers specialize in custom-branded cannabis accessories—grinders, rolling trays, storage solutions, and promotional items—that help Australian businesses create memorable impressions at conferences and trade shows. With no minimum order requirements and laser engraving capabilities, MunchMakers supports cannabis businesses of all sizes in building professional brand experiences that resonate with Australia's discerning medical cannabis community.

This comprehensive guide provides detailed information on major cannabis events scheduled across Australia from November 22, 2025, through June 30, 2026. We've curated this resource to help healthcare professionals, industry stakeholders, researchers, and advocates navigate Australia's evolving medicinal cannabis ecosystem through professional conferences, industry expos, cultural celebrations, and advocacy events.

Industry Snapshot: Cannabis in Australia (Late 2025/Early 2026)

The Regulatory Framework

Australia operates under a dual regulatory system for medicinal cannabis, with oversight shared between the Therapeutic Goods Administration (TGA) and the Office of Drug Control (ODC). Since 2016, medicinal cannabis has been legal across all six states and two territories, accessible to patients through two primary pathways: the Special Access Scheme (SAS) and the Authorised Prescriber (AP) scheme.

The SAS allows registered medical practitioners to prescribe medicinal cannabis products not included in the Australian Register of Therapeutic Goods (ARTG) to specific patients for specific conditions. The more streamlined SAS Category B (SAS-B) pathway has become the most common route, with over 113,000 applications approved in the first half of 2025 alone. The Authorised Prescriber scheme enables qualified doctors to prescribe specific medicinal cannabis products to a class of patients without requiring separate approval for each individual patient.

Only two cannabis products currently hold full registration on the ARTG: Epidyolex (cannabidiol) for certain epilepsy conditions, and Sativex Oromucosal Spray (nabiximols) for multiple sclerosis spasticity. However, over 450 unregistered medicinal cannabis products are available through the SAS pathways, spanning five categories based on THC and CBD content, from pure CBD formulations to high-THC medicines.

The ODC regulates and licenses the entire supply chain—cultivation, production, manufacturing, import, and export—ensuring compliance with the Narcotic Drugs Act 1967 and Australia's obligations under international drug control conventions. This comprehensive oversight aims to prevent diversion while facilitating legitimate medical access.

Market Growth and Patient Access

Australia's medicinal cannabis market is experiencing robust growth, with market valuations ranging from AUD$500-700 million at the patient level and projections suggesting compound annual growth rates between 20-33% through 2030. Patient numbers have expanded dramatically, with over 200,000 prescription approvals anticipated by year-end 2025, treating conditions including chronic pain, anxiety, sleep disorders, depression, epilepsy, and palliative care applications.

Interestingly, cannabis flower has overtaken oil-based products as the most prescribed dosage form—a reversal of earlier trends—reflecting patient preferences for inhalation methods and improved access to quality flower products. Survey data indicates that approximately 71% of Australian medical cannabis patients prefer inhaling cannabis to other consumption methods.

The rise of telehealth platforms has significantly improved patient access, with digital cannabis clinics streamlining the prescription process by connecting patients with Authorised Prescribers and handling product ordering through integrated systems. Companies like Alternaleaf (formerly Montu), Polln, CanView, and others have democratized access, particularly for patients in regional areas or those whose regular GPs remain unfamiliar with cannabis therapeutics.

Domestic Production vs. Imports

Australia's medicinal cannabis supply currently relies heavily on imports, primarily from Canada, which supplies surplus product to the Australian market. In 2023, Australia imported over 42,000 kilograms of medical cannabis products, while domestic cultivation produced approximately 26,593 kilograms (with 2,066 kilograms exported to international markets).

Domestic cultivators have expressed concerns about competing with imported products being "dumped" at lower prices due to Canada's oversupplied market. However, Australian producers emphasize their pharmaceutical-grade, GMP-certified cultivation practices and locally-tailored genetics as competitive advantages. Companies like Cann Group, Little Green Pharma, ECS Botanics, Zelira Therapeutics, Althea Group, and others continue investing in domestic production capacity and export market development, particularly targeting European markets showing strong demand.

Industrial Hemp Sector

Parallel to medicinal cannabis, Australia maintains a growing industrial hemp sector focused on low-THC cannabis cultivation (typically below 1% THC) for food, fiber, building materials, and wellness products. Hemp cultivation is regulated by both state and federal bodies, with emphasis on ensuring THC levels remain within legal limits.

Recent developments include innovative hemp varieties optimized for fiber applications, such as Hemp Farms Australia's "Wongarra" varietal showcased in 2025, demonstrating ongoing interest in sustainable industrial applications. The reclassification of low-dose CBD (up to 150mg/day) as a Schedule 3 substance opens potential over-the-counter availability for non-psychoactive wellness products, though no OTC cannabis products have yet received TGA approval.

Recreational Cannabis: The ACT Exception

Recreational cannabis remains illegal at the federal level throughout Australia. However, the Australian Capital Territory (ACT) has charted a distinct path, decriminalizing possession of small amounts (up to 50 grams dried or 150 grams fresh) and permitting adults to cultivate up to two plants per person (maximum four per household) since 2020. This ACT legislation represents Australia's most progressive cannabis policy, though it exists in tension with ongoing federal prohibition.

Advocacy for broader cannabis law reform continues through organizations like the Legalise Cannabis Party, Nimbin Hemp Embassy, and various patient advocacy groups, with ongoing discussions about potential recreational legalization, workplace drug testing reform (particularly for medical cannabis patients), and expanded access pathways.

The Event Ecosystem's Strategic Value

In Australia's maturing medicinal cannabis landscape, industry events serve multiple critical functions:

• Clinical Education: Healthcare conferences provide essential training for prescribers, pharmacists, and allied health professionals on cannabinoid medicine, prescribing protocols, dosing strategies, and patient management.
• Research Dissemination: Academic symposiums showcase emerging clinical research, patient outcome data, and scientific advances in cannabis therapeutics.
• Industry Development: Business conferences facilitate connections between cultivators, manufacturers, technology providers, investors, and distributors while showcasing cultivation innovations and processing technologies.
• Regulatory Updates: Events provide platforms for TGA officials, ODC representatives, and policy experts to discuss regulatory developments, compliance requirements, and access pathway improvements.
• Patient Advocacy: Conferences and cultural events amplify patient voices, share lived experiences, and advance cannabis law reform efforts.
• Investment Opportunities: Industry gatherings connect capital sources with Australian cannabis businesses seeking expansion funding or partnerships.
• International Collaboration: Events attract international speakers and attendees, facilitating knowledge exchange between Australia and mature global markets.

Understanding these functions helps participants select events aligned with their professional objectives and maximize returns from attendance investments.

Navigating Australia's Cannabis Event Landscape

Australia's cannabis event calendar encompasses several distinct gathering types, each serving specific audiences and purposes:

Medical Cannabis Conferences & Symposiums

Events like the Australian Medicinal Cannabis Symposium (UIC) and ANZCCP Conference focus primarily on clinical applications, prescribing practices, patient outcomes, and therapeutic research. These professional gatherings typically feature peer-reviewed presentations, continuing professional development credits for healthcare practitioners, and evidence-based discussions. Attendees include doctors, nurses, pharmacists, allied health professionals, researchers, and patient advocates seeking rigorous scientific discourse on cannabinoid medicine.

Industry Trade Conferences

Business-focused conferences like ACannabis bring together the commercial side of Australia's medicinal cannabis sector—cultivators, manufacturers, technology providers, investors, compliance specialists, and ancillary service providers. These events feature exhibition halls showcasing cultivation equipment, extraction technology, testing services, packaging solutions, and business support services, alongside educational programming on market trends, operational excellence, and regulatory compliance.

Hemp & Natural Products Expos

Events like the Hemp Health & Innovation Expo (HHI) serve both industry professionals and curious consumers, showcasing industrial hemp applications, CBD wellness products, sustainable textiles, hemp foods, building materials, and cultivation equipment. These gatherings typically blend education with consumer engagement, featuring workshops, speakers, and family-friendly activities that celebrate hemp's versatility beyond medicinal applications.

Cannabis Culture & Advocacy Events

Cultural celebrations like Nimbin MardiGrass combine activism with festival atmosphere, advocating for cannabis law reform while celebrating cannabis culture through protest rallies, competitions (Hemp Olympix), music performances, and community gatherings. These events attract a diverse mix of activists, cultural enthusiasts, patients, and supporters of cannabis policy reform.

Specialized & Academic Conferences

Australia hosts numerous specialized conferences examining specific topics within cannabis medicine and science—pharmacology, clinical trials, cultivation science, extraction chemistry, regulatory compliance, and more. These niche gatherings attract highly specialized audiences seeking deep technical knowledge.

Events At a Glance: November 2025 - June 2026

Important Notes: Australia's cannabis event calendar is more compact than North American markets, reflecting the sector's medical focus and smaller overall market size. The 2026 dates for several events (particularly ANZCCP and HHI Expo) have not been officially announced as of late 2025; dates shown are estimated based on historical patterns or represent typical scheduling. Always verify dates, locations, registration details, and program information on official event websites before making travel arrangements or commitments. Additional regional workshops, company-specific field days, and specialized academic conferences occur throughout the year but may not be widely promoted publicly.

Event Deep Dive: Major Australian Cannabis Gatherings

Maximizing Event ROI: Strategic Participation for Australian Cannabis Events

Successfully leveraging cannabis events in Australia's professional, medically-focused market requires preparation, appropriate positioning, and systematic follow-up. Whether attending as healthcare professional, industry exhibitor, researcher, or advocate, these best practices maximize returns:

Pre-Event Preparation

• Understand Your Audience: Australian cannabis events skew heavily toward medical professionals, researchers, and regulated industry stakeholders. Adjust messaging, materials, and approach accordingly—emphasize evidence, quality, compliance, and clinical value over recreational positioning or lifestyle branding.
• Define Clear Objectives: Are you seeking prescriber education opportunities? Looking for equipment suppliers or technology partners? Building relationships with researchers? Connecting with patient advocates? Clear goals drive strategic event selection and activity planning.
• Research Attendees and Speakers: Review conference programs, speaker lists, and (when available) attendee lists. Identify specific individuals or organizations you want to meet; reach out beforehand to schedule meetings or meals.
• Prepare Professional Materials: Ensure you have appropriate business cards, clinical literature (for healthcare audiences), product specifications (for B2B contexts), research summaries, and any necessary regulatory documentation. For medical conferences, peer-reviewed evidence carries more weight than marketing materials.
• Arrange Accommodation Early: Australian cannabis events often occur in cities with limited accommodation or during peak tourism periods. Book early for availability and rates. Consider staying at official conference hotels for networking opportunities.
• Review CPD Requirements: For healthcare professionals, verify which sessions qualify for continuing professional development credits and ensure proper attendance documentation.

Active Engagement During Events

• Prioritize Quality Over Quantity: Australia's smaller cannabis community means relationship quality matters more than networking card quantity. Invest time in substantive conversations rather than rapid-fire introductions.
• Attend Keynote and Plenary Sessions: These sessions often feature leading researchers, policy makers, or clinicians providing valuable insights. They also serve as shared reference points for subsequent conversations.
• Engage in Q&A and Discussions: Thoughtful questions during sessions demonstrate engagement and can lead to follow-up conversations. However, respect session format and time limits—don't monopolize discussion time.
• Leverage Networking Functions: Coffee breaks, lunches, and evening receptions facilitate more relaxed, substantive conversations than expo floor interactions. Come prepared with your value proposition but lead with curiosity about others' work.
• Visit Exhibitions Strategically: Walk exhibition halls systematically, introducing yourself to exhibitors aligned with your objectives. For exhibitors, ensure booth staffing by knowledgeable representatives who can have technical conversations, not just scan badges.
• Take Strategic Notes: Document key insights, research findings, regulatory updates, and contact information for follow-up. Use whatever system ensures you capture actionable information.
• Respect Professional Boundaries: Australia's medicinal cannabis sector operates under strict regulatory oversight. Healthcare professionals face professional obligations regarding evidence-based practice. Avoid overpromising, making unsubstantiated claims, or pressuring clinical decisions. Build trust through professionalism, transparency, and genuine value.

Systematic Post-Event Follow-Up

• Follow Up Promptly: Contact new connections within 3-5 business days while conversations remain fresh. Reference specific discussions to demonstrate genuine engagement.
• Provide Value First: Rather than immediately requesting meetings or sales conversations, offer something valuable—relevant research articles, introductions to others in your network, or insights related to expressed interests.
• Schedule Concrete Next Steps: Convert initial connections into specific actions—discovery calls, facility tours, product demonstrations, research collaborations, or follow-up meetings. Get commitments on calendars.
• Nurture Long-Term Relationships: Australia's smaller population and tight-knit professional communities mean reputation matters immensely. Short-term transactional thinking damages long-term prospects. Invest in authentic relationships, deliver on commitments, and recognize that today's connection may become tomorrow's strategic partner.
• Measure Results: Track metrics aligned with your objectives—prescriber relationships established, partnership discussions initiated, research collaborations formed, media coverage secured, investor conversations started. This data informs future event selection and participation strategies.
• Share Learnings Internally: For organizations, ensure event insights are documented and shared with relevant team members. Conference learnings should inform product development, regulatory strategies, clinical education programs, and business planning.

For Exhibitors: Professional Presentation

• Invest in Quality Booth Design: Australian cannabis events attract discerning professionals evaluating suppliers' credibility and quality standards. Professional booth design, clear messaging, and quality materials signal serious business operations.
• Staff with Knowledgeable Representatives: Ensure booth staff can discuss technical specifications, regulatory compliance, clinical applications, or research evidence as appropriate. General sales staff without technical knowledge undermine credibility in Australia's professional market.
• Provide Educational Value: Consider hosting booth presentations, demonstrations, or mini-workshops that educate rather than just promote. Healthcare audiences particularly value evidence-based education.
• Create Memorable Brand Experiences: Thoughtful branded giveaways create lasting impressions. Cannabis professionals appreciate quality accessories like precision grinders, elegant storage solutions, or useful tools—items they'll actually use that keep your brand visible. MunchMakers specializes in exactly these types of professional promotional items with no minimum orders, perfect for Australian businesses of any size creating memorable event presence.
• Capture Leads Systematically: Use lead capture technology (badge scanners, QR codes, digital forms) ensuring no connection falls through cracks. Develop qualification criteria to prioritize follow-up based on fit and buying authority.
• Consider Strategic Sponsorship: For major conferences, sponsorship packages often include speaking opportunities, premium booth placement, attendee list access, and branding throughout event materials. Evaluate whether sponsorship ROI justifies investment for your objectives.

Adapting to Australian Professional Culture

• Respect Evidence-Based Discourse: Australian medical cannabis discussions emphasize clinical evidence, peer-reviewed research, and rigorous science. Anecdotal testimonials or unsubstantiated claims damage credibility. Lead with data, acknowledge evidence gaps honestly, and position appropriately.
• Understand Regulatory Context: TGA regulations, ODC licensing, GMP requirements, and Poisons Standard classifications shape Australian cannabis conversations. Demonstrating regulatory knowledge signals serious market engagement.
• Acknowledge Cultural Differences: Australian professional culture values directness, authenticity, and unpretentiousness. Overly aggressive sales tactics or hyperbolic claims can backfire. Approach relationships with genuine curiosity, respect, and collaborative spirit.
• Build Long-Term Relationships: Australia's smaller population and tight-knit professional communities mean reputation matters immensely. Short-term transactional thinking damages long-term prospects. Invest in authentic relationships, deliver on commitments, and recognize that today's connection may become tomorrow's strategic partner.

Practical Considerations for Australian Cannabis Event Attendance

Travel & Logistics

Australian cannabis events occur primarily in major cities (Sydney, Melbourne, Brisbane) with excellent international and domestic flight connections, accommodation options, and transportation infrastructure. Brisbane and Melbourne offer modern convention centers near CBD areas with abundant hotels, restaurants, and public transport. Sydney events may occur at Olympic Park (requiring train or car access) or CBD venues. Nimbin MardiGrass requires additional planning, as the village is remote (1.5 hours inland from Byron Bay/Ballina airports); limited local accommodation means booking months ahead or staying in nearby towns like Lismore.

Regulatory & Legal Awareness

Cannabis laws vary significantly across Australian states and territories. While attending cannabis conferences is legal nationwide, actual cannabis products remain strictly controlled. Medicinal cannabis patients traveling to conferences should carry prescription documentation and be aware of state-specific regulations. Cannabis cannot be legally transported across state borders. Some events (particularly Nimbin MardiGrass) exist in complex legal spaces where cannabis cultural celebration occurs despite ongoing federal prohibition—attendees should exercise personal judgment about participation in any activities involving actual cannabis.

Professional Development & CPD

Many medical cannabis conferences offer continuing professional development (CPD) credits for AHPRA-registered healthcare professionals. Verify which sessions qualify for CPD, ensure proper attendance documentation, and maintain certificates for professional registration requirements. CPD availability makes conference attendance valuable professional investment beyond networking and education.

Budgeting for Events

Australian cannabis event costs vary by type and scale. Academic conferences typically charge AUD$400-800 for standard registration (often with early bird and member discounts). Industry conferences like ACannabis may charge AUD$500-1,200+ depending on access level. Cultural events like MardiGrass charge nominal entry fees (AUD$60-150). Budget also for accommodation (AUD$150-300+/night in major cities), meals, ground transportation, and potentially exhibition booth costs or sponsorships if exhibiting. Consider event participation as professional development or business development investment with ROI measured in relationships, knowledge, and opportunities generated.

Climate & Seasonal Considerations

February-March (late summer): Warm to hot weather in Brisbane (UIC Symposium); pack lightweight professional attire, stay hydrated. May (autumn): Pleasant mild weather in NSW for Nimbin MardiGrass; bring layers as nights can cool. Australian UV levels are intense—wear sunscreen for outdoor events. Conference venues maintain strong air conditioning; bring layers for temperature transitions.

Cultural Sensitivity & Inclusivity

Australia's medicinal cannabis sector involves diverse stakeholders including Aboriginal and Torres Strait Islander peoples with traditional relationships to plant medicines, patients from varied cultural backgrounds, healthcare professionals across specialties, researchers, industry operators, and advocates. Approach events with cultural sensitivity, respect for diverse perspectives, and recognition that cannabis discussions intersect with healthcare access, drug policy, Indigenous rights, and social justice issues.

Emerging Trends Shaping Australia's Cannabis Event Future

Telehealth Integration

Virtual cannabis clinics and telehealth platforms have democratized patient access, and future events will increasingly address digital health integration, remote patient monitoring, and technology-enabled prescribing. Expect more sessions on telehealth best practices, regulatory considerations, and platform comparisons.

Export Market Development

Australian cultivators increasingly target export markets (particularly Europe and UK) given domestic supply dynamics. Future industry conferences will likely expand programming on export regulations, international quality standards, global market opportunities, and cross-border partnerships.

Over-the-Counter CBD Products

The TGA's reclassification of low-dose CBD as Schedule 3 (potentially allowing OTC availability) represents a significant policy shift. As the first S3 CBD products move toward approval, expect expanded conference programming on OTC market strategies, consumer education, pharmacy relationships, and regulatory compliance for this emerging category.

Clinical Research Expansion

Australia continues building clinical research capacity in cannabinoid medicine, with universities, research institutions, and companies conducting trials. Academic conferences will increasingly feature Australian-led research, moving beyond international evidence toward locally-relevant data informing domestic prescribing.

Workplace & Driving Policy Reform

Medical cannabis patients face significant challenges with workplace drug testing and driving regulations that don't distinguish between impairment and mere presence of cannabinoids. Patient advocacy groups increasingly focus on these issues; expect policy-focused conference sessions addressing workplace accommodation, driving legislation reform, and patient rights protection.

Sustainability & Regenerative Agriculture

Environmental sustainability concerns are driving interest in regenerative cultivation practices, renewable energy integration, water conservation, and organic growing methods. Industry events will increasingly showcase sustainable cultivation innovations and environmental stewardship practices.

Conclusion: Engaging with Australia's Evolving Cannabis Sector

Australia's medicinal cannabis industry has achieved remarkable growth since federal legalization in 2016, evolving from tentative beginnings into a sophisticated, regulated healthcare sector delivering therapeutic options to over 200,000 patients annually. This maturation reflects expanding clinical understanding, improving regulatory frameworks, growing physician acceptance, and persistent patient advocacy—all advanced through the knowledge exchange, professional networking, and community building that occur at cannabis events across the country.

While Australia's cannabis event calendar appears modest compared to North America's extensive circuit, the concentrated nature of Australian gatherings creates strategic value. The same 100-200 key opinion leaders, prescribers, researchers, policy makers, and industry executives attend most major conferences, creating opportunities for relationship building, collaboration, and influence that might be diluted in larger, more fragmented markets.

For healthcare professionals, events like the UIC Australian Medicinal Cannabis Symposium and ANZCCP Conference provide essential education, peer learning, and professional community supporting cannabinoid medicine practice. For industry stakeholders, conferences like ACannabis facilitate business development, technology discovery, regulatory updates, and strategic partnerships driving commercial success. For advocates and cultural participants, gatherings like Nimbin MardiGrass maintain visibility for cannabis law reform while celebrating community, culture, and patient rights.

Success in Australia's medicinal cannabis sector increasingly depends on professional relationships, clinical credibility, regulatory competence, and genuine commitment to patient outcomes rather than pure commercial exploitation. Cannabis events provide concentrated opportunities to build these essential elements—learning from clinical leaders, understanding prescriber needs, staying current with regulatory developments, discovering innovative solutions, and positioning your organization as trusted partner in advancing Australia's cannabis healthcare sector.

As you plan your Australian cannabis event calendar for late 2025 and the first half of 2026, approach participation strategically. Define clear objectives aligned with your professional or business goals. Invest in preparation—understanding audiences, researching attendees, and preparing appropriate materials. Engage authentically during events—prioritizing quality relationships and substantive conversations over transactional networking. Follow up systematically, converting initial connections into ongoing relationships that generate value over time.

For businesses seeking to maximize event presence and create lasting professional impressions, strategic brand visibility matters. Custom-branded promotional items from specialized suppliers like MunchMakers—offering precision grinders, elegant storage solutions, professional accessories, and quality promotional merchandise with no minimum orders—help Australian cannabis businesses stand out at conferences and build brand recognition in this growing professional sector. Quality branded items that attendees actually use represent high-ROI marketing investments in Australia's relationship-focused cannabis community.

Australia's medicinal cannabis future continues unfolding through ongoing research, policy evolution, market development, and clinical innovation. The healthcare professionals, researchers, industry leaders, patients, and advocates gathering at conferences across the country are actively shaping that future through their work, collaborations, and collective commitment to improving patient access to quality cannabis therapeutics.

Will you be part of that conversation? The invitations are extended. The opportunities are present. The question is whether you'll show up, engage meaningfully, and convert these gatherings into the professional relationships, clinical knowledge, business partnerships, and strategic insights your work requires to thrive in Australia's dynamic medicinal cannabis sector.

See you at the conferences—where Australia's cannabis healthcare future is being built, one relationship and one evidence-based conversation at a time.

Additional Resources for Australian Cannabis Professionals

Industry Publications & News Sources

• Cannabiz: Leading Australian medicinal cannabis industry news and analysis
• Insight+: Healthcare news covering medicinal cannabis developments
• Australian Cannabis News: Industry updates and regulatory news
• Hemp Gazette: Hemp industry news and developments
• MJBizDaily Australia: Australian coverage from global cannabis business news leader

Industry Associations & Professional Organizations

• Medicinal Cannabis Industry Australia (MCIA): Primary industry trade association—mcia.org.au
• Australian Medicinal Cannabis Association (AMCA): Professional association for healthcare providers—ausmca.org
• Australian and New Zealand College of Cannabinoid Practitioners (ANZCCP): Professional college for prescribers—anzccp.org
• Legalise Cannabis Party: Political party advocating cannabis law reform—legalisecannabis.org.au

Government & Regulatory Resources

• Therapeutic Goods Administration (TGA): Medicinal cannabis regulatory information—tga.gov.au
• Office of Drug Control (ODC): Cannabis licensing and cultivation regulation—odc.gov.au
• Commonwealth Department of Health: National medicinal cannabis framework—health.gov.au

Research & Clinical Resources

• Lambert Initiative for Cannabinoid Therapeutics (University of Sydney): Leading Australian cannabis research center
• Tilray Medical Australia: Patient educational resources and clinical information
• Australian Medicinal Cannabis Research Network: Collaborative research initiatives
• PubMed/Medical Literature Databases: Peer-reviewed cannabis research publications

Patient Access & Telehealth Platforms

• Alternaleaf (formerly Montu): Leading telehealth cannabis clinic
• Polln: Cannabis telehealth and pharmacy services
• CanView: Medicinal cannabis product and prescription management platform
• Doctors on Demand: Virtual healthcare including cannabis consultations
• CDA Clinics: Nationwide medicinal cannabis clinics

Disclaimer

This guide provides general information about Australian cannabis events scheduled between November 22, 2025, and June 30, 2026. Event details including dates, locations, programming, speakers, and registration requirements are subject to change by organizers without notice. Readers should verify all information directly with official event websites before making travel arrangements, registration commitments, or business decisions. This guide does not constitute medical, legal, financial, or business advice. Cannabis regulations vary significantly across Australian states and territories and at the federal level; readers are solely responsible for understanding and complying with applicable laws in their jurisdictions. Healthcare professionals should ensure their prescribing practices align with TGA regulations, AHPRA professional standards, and applicable state/territory laws. The inclusion of events, companies, or organizations in this guide does not constitute endorsement. Information presented represents publicly available data as of late November 2025. The Australian cannabis landscape continues evolving rapidly; readers should supplement this guide with current research and professional advice appropriate to their specific circumstances.